Toni Wyllie

Senior Bioconjugation Scientist

[Iksuda Therapeutics @IksudaT]

March 8th is #InternationalWomensDay so we're celebrating the women who've helped shape the world we live in💜

We're also celebrating women who are shaping the world of tomorrow, like our team here at Iksuda!💪

Here's to all the amazing women in the world of science and beyond!

[Iksuda Therapeutics @IksudaT]

We'll be off to Boston later this month as Toni Pringle is attending the 4th Annual Novel Conjugates Summit!

We hope to see you there, if you see us come say hello 👋

[Iksuda Therapeutics @IksudaT]

Today we enjoyed an employee wellbeing session at a local café called the Dog and Scone! 🍰🐶
#EmployeeWellbeing #Stressrelief #TeamBonding

[Iksuda Therapeutics @IksudaT]

We're looking forward to seeing what day 1 of #WorldADC2024 brings! 🙌

[RSC Advances @RSCAdvances]

@RSCAdvances is delighted to announce our 2022 Outstanding Student Paper Award winners. These awards recognise outstanding research in 2022 conducted by a student.

Discover our winners here 📣 https://t.co/OrwnVx4wmO
Full collection: https://t.co/zsLp8hL6FB

[Bone Cancer Research Trust @BCRT]

It was great to hear from Mr Rankin about using a dye (ICG) to highlight sarcomas, potentially improving surgical removal of the entire tumour. A @BCRT funded consortium helps researchers drive these techniques for bone cancer patients.
https://t.co/sJ2KvM2KeB #BSGConf2023

[Bone Cancer Research Trust @BCRT]

MORE breaking news this #WorldCancerDay 🌎 We're connecting one of the UK's leading oncologists, Mr Kenny Rankin at @UniofNewcastle, with fellow experts worldwide to improve bone cancer surgery 🏥 Find out more: https://t.co/WWAcRQ39jj #Research #Collaboration #UntilTheresACure

[Toni Wyllie @ToniWyllie]

@Nichola81832842 @Paterson_Group @UQ_CAI @NIFAus @ThurechtGroup @AIBNatUQ Utterly! 🎉🎉

[JamesKnightLab @knight_lab]

Brilliant seminar today by @syaterry who gave a fascinating overview of her radionuclide therapy research - cant wait to see where it leads! @ChemistryNCL @KingsCollegeLon #nuclearmedicine

[RSC Advances @RSCAdvances]

Check out our latest #RSCAdvPopular blog featuring Dr James Knight!👇
https://t.co/Fyo1krOA31
@knight_lab👨‍🔬discusses his paper exploring antibody - cell penetrating peptide conjugates
@ToniPringle9👩‍🔬led the research
@ChemistryNCL @SciencesNCL @KawamuraGroup

[Toni Wyllie @ToniWyllie]

Honoured that my recent paper exploring Ab:CPP ratios has been selected to be featured in the ⁦@RSCAdvances⁩ "2022 Popular Advances Collection"! ⁦@knight_lab⁩ ⁦@ChemistryNCL⁩ ⁦@SciencesNCL⁩ ⁦@KawamuraGroup⁩ https://t.co/jeGx4MLPpx

[Toni Wyllie @ToniWyllie]

Had a great time at the GSK Biopharm conference 2022, seeing some superb talks and posters and touring the GSK labs.

Super proud to have won the 1st place poster presentation also! 🏆

@knight_lab @ChemistryNCL

[The Nobel Prize @NobelPrize]

BREAKING NEWS:
The Royal Swedish Academy of Sciences has decided to award the 2022 #NobelPrize in Chemistry to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless “for the development of click chemistry and bioorthogonal chemistry.”

[Toni Wyllie @ToniWyllie]

Had a great time at #WMIC2022 in sunny (after the hurricane) Miami presenting my two posters and watching some really great presentations @ChemistryNCL @knight_lab

[Toni Wyllie @ToniWyllie]

Our recent paper exploring the influence of cell penetrating peptide DOLs on specific cell internalisation of Ab-CPP conjugates is finally out!! 🧪⁦@knight_lab⁩ ⁦@ChemistryNCL⁩ ⁦@KawamuraGroup⁩ https://t.co/e8J0wNypV5

[Bioconjugate Chem @BioconjChem]

Pringle et al. @UniofNewcastle developed an imaging agent based on a site-specifically glycoengineered anti-MT1-MMP #immunoconjugate for pre-operative PET-based assessment & intraoperative fluorescence-guided surgery of MT1-MMP-overexpressing #sarcomas. https://t.co/lhLWeBkKER

[UK Research and Innovation @UKRI_News]

NEW: We're increasing our minimum student stipend by 10% from 1 October 2022. Full details: https://t.co/hhmtX95OVW

[JamesKnightLab @knight_lab]

Cover art for our latest article drawn by @ToniPringle9 reflects the development of an MT1-MMP PET/NIRF probe and evaluation in a model of dedifferentiated chondrosarcoma. w/ Kenny Rankin @coreychan95 @hjblair1 & Saimir Luli https://t.co/8Ys6yxROgI @OR_UK @ChemistryNCL @NU_Cancer